跨扫描仪和跨示踪剂深度学习从低剂量PET恢复标准剂量成像质量
该研究开发了一种条件生成对抗网络(GAN),用于在不同扫描仪和示踪剂上从低剂量PET恢复高质量成像。在[18F]FDG、[18F]FET和[18F]Florbetapir脑PET图像上测试,AI恢复的改善与基线图像质量(SSIM)和归一化剂量采集显著相关,物理和临床图像评估均显示该方法有效。
要点
- AI恢复的改善与基线图像质量(SSIM)显著相关(r=-0.71,p<0.05)。
- AI恢复的改善与归一化剂量采集显著相关(r=-0.60,p<0.05)。
- 跨扫描仪和跨示踪剂AI方法在物理和临床图像评估上均显示有效(p<0.05)。
核心结论
- 深度学习在未知扫描仪和示踪剂上的可扩展应用可能提高基于AI的剂量降低的可信度和临床可接受性。
研究设计与样本
- 使用单扫描仪采集的237例患者脑[18F]FDG PET图像开发AI技术,随后在3种不同扫描仪的45例[18F]FDG PET、2种不同扫描仪的18例[18F]FET PET以及10例[18F]Florbetapir图像上测试;定制条件生成对抗网络(GAN)进行跨扫描仪和跨示踪剂优化,由3名核医学医生独立评估临床效用。
主要发现
- AI恢复的改善与结构相似性指数测量(SSIM)显著相关(r=-0.71,p<0.05),与归一化剂量采集显著相关(r=-0.60,p<0.05);跨扫描仪和跨示踪剂AI方法在物理和临床图像评估上均显示有效(p<0.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: A critical bottleneck for the credibility of artificial intelligence (AI) is replicating the results in the diversity of clinical practice. We aimed to develop an AI that can be independently applied to recover high-quality imaging from low-dose scans on different scanners and tracers. METHODS: Brain [18F]FDG PET imaging of 237 patients scanned with one scanner was used for the development of AI technology. The developed algorithm was then tested on [18F]FDG PET images of 45 patients scanned with three different scanners, [18F]FET PET images of 18 patients scanned with two different scanners, as well as [18F]Florbetapir images of 10 patients. A conditional generative adversarial network (GAN) was customized for cross-scanner and cross-tracer optimization. Three nuclear medicine physicians independently assessed the utility of the results in a clinical setting. RESULTS: The improvement achieved by AI recovery significantly correlated with the baseline image quality indicated by structural similarity index measurement (SSIM) (r = -0.71, p < 0.05) and normalized dose acquisition (r = -0.60, p < 0.05). Our cross-scanner and cross-tracer AI methodology showed utility based on both physical and clinical image assessment (p < 0.05). CONCLUSION: The deep learning development for extensible application on unknown scanners and tracers may improve the trustworthiness and clinical acceptability of AI-based dose reduction.
引用
- Xue S, Guo R, Bohn KP, et al. A cross-scanner and cross-tracer deep learning method for the recovery of standard-dose imaging quality from low-dose PET. Eur J Nucl Med Mol Imaging. 2021. PMID: 34950968. doi:10.1007/s00259-021-05644-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。